Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FSPG Imaging for Cardiac Sarcoidosis
NCT03103490Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Aug 2017
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Stanford University. Primary endpoint: Number of Participants With 18F-FSPG Uptake on PET/MRI or PET/CT Fused Images Indicating Cardiac Involvement of Sarcoidosis at 2 hours. Started Aug 2017; status: terminated.
Beyond the preview
Go deeper on NCT03103490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103490.